MRUS News and Press, Merus N.V.

UTRECHT, The Netherlands and CAMBRIDGE, Mass., July 24, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics ® and Triclonics ® ), tod...

2024-07-15 11:10:00 ET Summary TimesSquare Capital U.S. Small Cap Growth portfolio outperformed the Russell 2000® Growth Index in the second quarter. The second quarter was good for the equity markets—provided one only owned a handful of the largest, most growthy, U.S....

2024-07-13 04:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-07-09 07:00:00 ET Summary Biotech indexes lagged broader market indexes in the first half of 2024, and trade at the same level as in early 2022. Biotech valuations are closely tied to the Fed's interest rate policy and are highly correlated to the 10-year yield. Inflation...

UTRECHT, The Netherlands and CAMBRIDGE, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics ® and Triclonics ® ), tod...

2024-07-01 08:11:31 ET More on Merus Merus Stock: Priced High After An ASCO Surprise Surge (Maintain Buy) Merus announces pricing of upsized public offering of common shares Read the full article on Seeking Alpha For further details see: Merus names Fabia...

UTRECHT, The Netherlands and CAMBRIDGE, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics ® and Triclonics ® ), today a...

2024-06-27 10:45:04 ET Aurora Innovation Inc (AUR) AUR is trading UP for the last 5 days, and it at trading at $2.79 with volume of 1,962,658 and a one day change of $0.15 (5.67%). Aurora Innovation Inc has a 52-week low of 1.30 and a 52-week high of $4.81. The business's 50-day mov...

2024-06-17 09:00:05 ET Bradley Canino from Stifel Nicolaus issued a price target of $99.00 for MRUS on 2024-06-17 07:26:00. The adjusted price target was set to $99.00. At the time of the announcement, MRUS was trading at $56.55. The overall price target consensus is at ...

2024-06-04 09:00:06 ET Asthika Goonewardene from Truist Financial issued a price target of $88.00 for MRUS on 2024-06-04 08:08:00. The adjusted price target was set to $88.00. At the time of the announcement, MRUS was trading at $52.94. The overall price target consensus...